Ferayorni Justin John 4
4 · STREAMLINE HEALTH SOLUTIONS INC. · Filed May 27, 2021
Insider Transaction Report
Form 4
Ferayorni Justin John
Director
Transactions
- Award
Common Stock, $0.01 par value
2021-05-20$2.00/sh+37,500$75,000→ 142,681 total
Holdings
- 4,930,882
Common Stock, $0.01 par value
Footnotes (4)
- [F1]The reported securities represent 4,433,334 shares held directly by Tamarack Global Healthcare Fund, L.P. ("Fund 1") and 497,548 shares held directly by Tamarack Global Healthcare Fund QP, L.P. ("Fund 2"). Tamarack Capital Management, LLC is the general partner of Fund 1 and Fund 2, Tamarack Advisers, LP is the investment adviser to Fund 1 and Fund 2, and Justin J. Ferayorni is the sole managing member of both Tamarack Capital Management, LLC and Tamarack Capital GP, LLC. Tamarack Capital Management, LLC, Tamarack Advisers, LP, and Mr. Ferayorni may be deemed indirect beneficial owners of the shares held by Fund 1 and Fund 2 for purposes of Section 13(d) of the Securities Exchange Act of 1934 (the "Act").
- [F2]Tamarack Capital Management, LLC, Tamarack Advisers, LP, and Mr. Ferayorni disclaim beneficial ownership of any of the shares held by Fund 1 and Fund 2 for the purpose of determining whether they are subject to Section 16 of the Act, however, in reliance on Rule 16a-1(a)(1)(v) and (vii) under the Act. To the extent that they might be deemed subject to Section 16, they disclaim beneficial ownership of securities held by the Fund 1 and Fund 2 for purposes of Rule 16a-1(a)(2), except to the extent of their pecuniary interest therein, if any.
- [F3]Grant of restricted stock that vests in full on the earlier of (i) May 20, 2022 and (ii) the date of, and immediately prior to, the Company's 2022 annual meeting of stockholders.
- [F4]The reported securities represent shares owned directly by Mr. Ferayorni.